The Over/Under On Cannabis MSOs
Marijuana growers in the U.S. have it harder than their Canadian counterparts, but a team of analysts at one firm are bullish on a select… Read More »The Over/Under On Cannabis MSOs
Marijuana growers in the U.S. have it harder than their Canadian counterparts, but a team of analysts at one firm are bullish on a select… Read More »The Over/Under On Cannabis MSOs
Last year, this biotech firm had a $50 stock and $3 billion market cap. Today, it has a stock trading below $16 and a market… Read More »A Treatment That Improves The Condition Of MS Patients Could Improve The Condition Of This Beaten-Up Biotech
The eSports industry is experiencing explosive growth – and a new ETF offers investors pure exposure to all areas of the space, from video game… Read More »This New ETF Is King Of The NERDs
Should you order up some alternative meat stocks for your portfolio? The much-hyped space may not be as juicy as it appears – and pure-play… Read More »An Alternative Take On Alternative Meat Stocks
The shift towards electric vehicles may be happening at a much faster speed than many (including many investors) appreciate – and there are many more… Read More »Getting In The Fast-Moving Electric Vehicle Trend
They may be dinged, scratched or dented, but these companies are far from junk. Rather, says one outperforming fund manager, they are high-quality companies that… Read More »These Stocks Are Dented, But Far From Dead
With unreasonably high valuations, increasing risks and fading momentum, the bull market in medical devices may be coming to an end soon. For those seeking… Read More »Trade Medical Device Stocks For This Other ‘Aging Population’ Play
Wall Street is shunning this retailer, lumping it in with the likes of Macy’s and J. C. Penney. But with its strong e-commerce business, generous… Read More »This Shunned Stock Could Be A Retail Survivor
Amid an escalating trade war and increasing market volatility, one of the very few ‘bright spots’ in the markets – outside of precious metals –… Read More »Charting Solar’s Path
Two small biotech companies focused on underserved medical needs and patient populations – including neuropsychiatric/neurological disorders and women’s health issues – are among five Buy-rated… Read More »Big Upside Potential At Low Prices For Aggressive Traders